WHO Director-General Tedros Adhanom Gabrieus

Global vaccine-sharing program reaches 1b doses

eAwaz Medicine

BRUSSELS (Reuters) – The Covax global vaccine-sharing program has delivered 1 billion COVID-19 vaccine doses, one of the organizations which manages it said. Supplies to poorer nations have long been very limited because of lack of vaccines, as wealthier states secured most of the doses initially available from December 2020. But in the last quarter shipments have exponentially increased, allowing …

Merck Ridgebacks Molnupiravir

WHO is reviewing Merck’s oral pill 

eAwaz Medicine

Washington – The WHO is currently reviewing Merck’s COVID-19 antiviral oral pill molnupiravir and it is thought that a recommendation will likely be made by early February. According to Janet Diaz, WHO lead on clinical management, WHO’S Guidelines Development Group is also getting ready to review Pfizer’s oral pill.


Oral antiviral pill Molnupiravir best for Covid

eAwaz Medicine

Washington – Health experts say Molnupiravir – an oral antiviral pill approved for treating Covid-19, says the benefits of the drug outweigh potential risks it may have in the case of high-risk patients. Developed by US-based drug company Merck, Molnupiravir is approved by the US Food and Drug Administration against Covid-19. It is also approved by the UK Medicines and …

National Advisory Committee on Immunizations

Why 4th Covid-19 vaccine dose?

eAwaz Medicine

Ontario – As the highly transmissible Omicron variant of COVID-19 surges across the country, Canada’s National Advisory Committee on Immunization (NACI) has recommended that moderately or severely immunocompromised Canadians may receive a second booster or fourth shot at least six months after their last dose. “Many of these individuals are at a higher risk of severe outcomes of COVID-19 and …

Moderna Chief Executive Stephane Bancel

Moderna CEO: People may need 4th Covid shot 

eAwaz Medicine

Washington – Moderna CEO Stephane Bancel has said the efficacy of boosters against Covid-19 will likely decline over time, and a fourth shot will be required to increase their protection. Bancel said people who received their boosters last fall will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape …